Atlas Trials

Phase I Dose Escalation SARS-CoV Recombinant S Protein, With and Without Adjuvant, Vaccine Study

Clinical trial NCT01376765 · WITHDRAWN

Trial details

NCT number
NCT01376765
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
SARS
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.